Parkinson's disease is a progressive neurodegenerative brain disorder that causes tremors and slowly diminishes movement over time. In the U.S, an estimated one million individuals are affected by the disease, and some 60,000 new cases emerge every, even as its cause is still unknown, a cure doesn’t seem to be on the horizon. Source http://www.pdf.org/about_pd However, more and more studies are emerging that challenges conventional wisdom that tells us that Parkinson’s disease is isolated to the brain. A new study suggests that doctors and researchers may have been focused on the wrong place in the body. Instead of the brain, Parkinson’s disease is now believed to be linked to abnormalities in the gut. This notion is not far-fetched and actually
…show more content…
If Parkinson’s disease indeed originates in the gut, CBD could aid in treating the gastrointestinal issues associated with the condition. Lacking are direct studies offering substantial findings connecting CBD to gut bacteria in patients suffering from Parkinson’s disease. Available are findings on how CBD could help in the treatment of specific gastrointestinal disorders. These studies are a good indication of how CBD may also help with issues of a similar nature associated with Parkinson’s disease. Cannabinoids are known to be beneficial in the treatment of gastrointestinal disorders, such as gastrointestinal pain, gastroenteritis, and diarrhea. Cannabinoids exert their effects on the gastrointestinal tract by activating CB1 and CB2 receptors, located in various areas of the body’s endocannabinoid system. CB1 receptors are present to a high degree in regions of the brain, while CB2 receptors are in immune cells. When functional changes occur in the body that stems from the presence of an illness, the endocannabinoid system conveys protection to the gastrointestinal tract from inflammation and abnormally high gastric and enteric secretion. Source https://www.ncbi.nlm.nih.gov/pubmed/16751708 As a protective agent, the endocannabinoid system may represent a new way to use CBD oil as a therapeutic target against gastrointestinal problems associated with Parkinson’s
If Parkinson’s disease indeed originates in the gut, CBD could aid in treating the gastrointestinal issues associated with the condition. Lacking are direct studies offering substantial findings connecting CBD to gut bacteria in patients suffering from Parkinson’s disease. Available are findings on how CBD could help in the treatment of specific gastrointestinal disorders. These studies are a good indication of how CBD may also help with issues of a similar nature associated with Parkinson’s disease. Cannabinoids are known to be beneficial in the treatment of gastrointestinal disorders, such as gastrointestinal pain, gastroenteritis, and diarrhea. Cannabinoids exert their effects on the gastrointestinal tract by activating CB1 and CB2 receptors, located in various areas of the body’s endocannabinoid system. CB1 receptors are present to a high degree in regions of the brain, while CB2 receptors are in immune cells. When functional changes occur in the body that stems from the presence of an illness, the endocannabinoid system conveys protection to the gastrointestinal tract from inflammation and abnormally high gastric and enteric secretion. Source https://www.ncbi.nlm.nih.gov/pubmed/16751708 As a protective agent, the endocannabinoid system may represent a new way to use CBD oil as a therapeutic target against gastrointestinal problems associated with Parkinson’s